The utility of transgenic mouse models in the study of cutaneous immunology and inflammation

Journal of Dermatology

Volumn 23, Issue 11, 1996, Pages 741-745

  Kupper, Thomas S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GENE PRODUCT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; PADGEM PROTEIN; SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CELL JUNCTION; CELL SURFACE; CONFERENCE PAPER; DERMOEPIDERMAL JUNCTION; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOLOGY; INFLAMMATION; KERATINOCYTE; LEUKOCYTE ACTIVATION; PROMOTER REGION; SKIN INFLAMMATION; TRANSGENE; TRANSGENIC MOUSE;

EID: 0029826154     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1996.tb02695.x     Document Type: Conference Paper

References (26)

1. Williams IR, Kupper TS: Immunity at the surface: Homeostatic mechanisms of the skin immune system, Life Sciences, 58: 1486-1507,1996.
2. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation, / Invest Dermatol, 105: 62s-66s, 1995.
3. Luger TA, Schu-arz T: The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation, Allergy, 50: 292-302,1995.
4. Zinkel S, Fuchs E: Skin cancer and transgenic mice, Semin Cancer Biol, 5: 77-90,1994.
5. Greenhalgh DA, Roop DR: Dissecting molecular carcinogenesis: Development of transgenic mouse models by epidermal gene targeting, Adv Cancer Res, 64: 247-296,1994.
6. Vassar R, Roscnberg M, Ross S, Tyner A, Fuchs E: Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice, Proc Natl Acad Sei (USA), 86: 1563-1567, 1989.
7. Bailleul B, Surani MA, White S, et al: Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter, Cell, 62: 1697-1708, 1990.
8. Carroll JM, Romero MR, Watt FM: Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis, Cell, 83: 957-968, 1995.
9. Takahashi K, Folmer J, Coulombe PA: Increased expression of keratin 16 causes anomalies in cytoarchitecture and keratinization in transgenic mouse skin,/ Cell Biol, 127:505-520, 1994.
10. Beermann F, Schmid E, Ganss R, Schutz G, Ruppert S: Molecular characterization of the mouse tyrosinase gene: Pigment cell-specific expression in transgenic mice, Pigment Cell Kes, 5: 295-299, 1992.
11. Grossman R, KruegerJ, Yourish D, et al: Involvement of interleukin G in the pathogenesis of psoriasis, Proc Natl Acad Sei (USA), 86: 6367-6371,1989.
12. Turksen K, Kupper TS, Degenstein L, Williams I, SarkarS, Fuchs E: IL-6: Insights to its function in skin by expression in transgenic mice, Proc Natl Acad Sei (USA), 89: 5068-5072, 1992.
13. Viac J, Schmitt D, Claudy A: Molecules d'adhésion et dermatoses inflammatories [Adhesion molecules and inflammatory dermatoses], Allerg Immunol (Paris), 26: 274-277, 1994.
14. Williams IR, Kupper TS: Epidermal ICAM-1 is not a primary inducer of cutaneous inflammation in transgenic mice, Proc Natl Acad Sei (USA), 91: 9710-9714, 1994.
15. Springer TA: Tarffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell, 76: 301-314, 1994.
16. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis, Science, 272: 60-66, 1996.
17. Klipper TS: Immune and inflammatory processes in cutaneous tissues: Mechanism and speculations (Perspectives article), J Clin Invest, 86: 1783-1789, 1990.
18. Wood LC, Elias PM, Calhoun C, et al: Barrier disruption stimulates interleukin-lo expression and release from a pre-formed pool in murine epidermis, J Invest Derinatol, 106: 397-403,1996.
19. Groves RW, Mizutani H, Kiefïer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin la in basal epidermis, Proc Natl Acad Sei (USA), 92: 1585-1591,1995.
20. ChengJ, Turksen K, Yu'GC, Schreiher H, Teng M, Fuchs E: Cachexia and graft-vs-host-disease-tpe skin changes in keratin promoter-driven TNF alpha transgenic mice, Genes Dev, 6: 1444-1456, 1992.
21. Nakamura K, Williams LF, Kupper TS: Keratinocytederived monocyte chemoattractam protein I (MCP-l): Analysis in a transgenic model demonstrates MCP-l can recruit dendritic and Langerhans cells to skin, J Invest Dennatol, 105: 635-643, 1995.
22. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein 1 as a T-lymphocyte chemoattractant, Proc Natl Acad'Sci (USA), 91: 3652-3656,1994.
23. Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS: Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type 1) on epidermal keratinocytes: Evidence that IL-1 inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease.y Clin Invest, (in press)
24. Lennard AC: Interleukin-1 receptor antagonist, Crit Rev Immiinol, 15: 77-105, 1995.
25. Rauschmayr T, Kupper TS: Unpublished observations.
26. Williams IR, Ort R, Kupper TS: Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune responses to cutaneous antigens, Proc Nail Acad Sei (USA), 91: 12780-12784,1994.